Daniel Vasella, CEO Novartis, left, smiles next to Raymund Breu, Chief Financial Officer, right, during the 2008 full-year results press conference in Basel, Switzerland, Wednesday, Jan. 28, 2009. Drugmaker Novartis AG reported a 62 percent rise in fourth quarter net profit Wednesday, Jan. 28, 2009 helped by steady sales growth and the absence of restructuring charges that had hindered the previous year's results. The company said net income rose to US$1.507 billion from 931 million in the fourth quarter of 2007. AP Photo logo AP Photo 10 months ago

Daniel Vasella, CEO Novartis, left, smiles next to Raymund Breu, Chief Financial Officer, right, during the 2008 full-year results press conference in Basel, Switzerland, Wednesday, Jan. 28, 2009. Drugmaker Novartis AG reported a 62 percent rise in fourth quarter net profit Wednesday, Jan. 28, 2009 helped by steady sales growth and the absence of restructuring charges that had hindered the previous year's results. The company said net income rose to US$1.507 billion from 931 million in the fourth quarter of 2007.